Here’s what you need to know:
1. The U.S. imports roughly 30 percent of its medical devices and supplies. Annual imports of medical devices tripled from 2001 to 2016, reaching $43.9 billion.
2. Relocating these companies and jobs to the U.S. would be a lengthy process because of the time-consuming FDA-approval process.
3. If device companies continue making their products outside of the U.S., they may soon be subjected to new taxes on imports, raising device prices and shaking up U.S. healthcare altogether.
4. U.S.-based hospitals rely on devices and products made in China, Ireland, Mexico, Germany and more.
5. While Premier COO Mike Alkire admitted device prices would initially spike if foreign countries were hit with tariffs, he said, “Over the long term…we do think the market will stabilize and the most efficient place to produce products will occur.”
More articles on devices:
Dr. Michael Fehlings to head 1st Canadian site for InVivo’s cervical spinal cord injury study — 7 things to know
DePuy Synthes launches new arthroscopic solutions — 4 observations
DePuy Synthes launches ATTUNE Revision Fixed Bearing Tibial Base and Cemented Stem — 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
